Haleon stock outlook cut as Q3 growth falls short of expectations

Published on 11/01/2026 at 12:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Haleon stock faces a tougher growth outlook after a weaker third quarter. Management is pairing operational changes with continued capital returns.

Growth reset and capital returns

Haleon's third-quarter organic revenue growth reached 2.6%, led by Oral Health.
Soft cough, cold and flu consumption and a China classification change weighed on performance.
Management maintained its high-single-digit adjusted operating profit growth outlook at constant currency.

Haleon, GB00BMX86B70, Illustration mit AI erstellt.

Haleon reported a mixed third quarter on Thursday, October 29, 2026, prompting a reset in its growth outlook while preserving its profit target and expanding its share buyback. The company reported the figures in its 2026 Q3 Trading Statement.

Quarterly growth loses momentum

Haleon generated GBP 2,868 million in reported revenue in the three months to September 30. Organic revenue growth was 2.6%, supported by a 2.1% pricing contribution and 0.5% from volume and mix.

Oral Health remained the strongest category, with organic growth of 8.8%. Respiratory Health declined 2.0% organically, as softer cough, cold and flu consumption reduced orders in North America. Haleon also said a raw material classification change affected Centrum over-the-counter products in China; the company said the issue was unrelated to product quality or safety.

Outlook shifts while buyback expands

Haleon now expects full-year 2026 organic revenue growth to be around 2.5%. It continues to expect high-single-digit adjusted operating profit growth at constant currency. The company also expects its accelerated go-to-market changes in Brazil to reduce fourth-quarter net revenue by GBP 15 million to GBP 20 million.

Haleon allocated a further GBP 500 million to share buybacks, with completion targeted by the 2026 full-year results in February 2027. For investors, the update points to a sharper focus on volume growth and execution, while the unchanged profit outlook indicates that productivity and margin management remain central to the investment case.

Latest trading reference

Haleon stock last traded at EUR 3.88 on Lang & Schwarz at 12:59 Berlin time on Saturday, October 31, 2026. The real-time quote of Haleon stock remains the clearest reference for the latest available trading indication.